{
    "Trade/Device Name(s)": [
        "N Antisera to Human \u03b11-Antitrypsin",
        "N Antisera to Human \u03b11-Antitrypsin Assay"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K053072",
    "Predicate Device Reference 510(k) Number(s)": [
        "K860894"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DEM"
    ],
    "Summary Letter Date": "March 28, 2006",
    "Summary Letter Received Date": "November 1, 2005",
    "Submission Date": "October 28, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5130"
    ],
    "Regulation Name(s)": [
        "Alpha-1-Antitrypsin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Alpha-1-antitrypsin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BN Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunonephelometry"
    ],
    "Methodologies": [
        "Immunochemical reaction",
        "Immunonephelometry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for N Antisera to Human \u03b11-Antitrypsin assay using immunonephelometry for quantitative determination in serum and plasma",
    "Indications for Use Summary": "Quantitative determination of alpha-1-antitrypsin in human serum, heparinized and EDTA plasma to aid in diagnosis of conditions including adult cirrhosis and alpha-1-antitrypsin deficiency associated with pulmonary emphysema, using BN Systems",
    "fda_folder": "Immunology"
}